Inception Return
(12/11/1995)
|
8.95 %
|
|
YTD Return
|
24.89 %
|
|
NAVPS
(10/21/2024)
|
$78.86
|
|
Change
|
$0.20 / 0.25 %
|
|
|
Growth of $10,000
(As of September 30, 2024)
|
|
MER
|
2.20 %
|
|
Assets ($mil)
|
$491.61
|
|
Rank (1Yr)
|
122/1973
|
|
Std Dev (3Yr)
|
16.00 %
|
|
Volatility Ranking (3Yr)
|
8/10
|
|
RRSP Eligibility
|
Yes
|
|
Load
|
No Load
|
|
Max Front End
|
-
|
|
Max Back End
|
-
|
|
Sales Status
|
Open
|
|
|
Objective
To provide long-term growth through capital appreciation by investing globally, primarily in companies that are involved in the development, application, production, or distribution of scientific and technology-based products and services.
|
Fund Manager
Canadian Imperial Bank of Commerce
Portfolio Manager
CIBC Asset Management Inc.
Sub-Advisor
Data not available
|
|
Asset Allocation
(As of September 30, 2024)
|
Sector Allocation
(As of September 30, 2024)
|
Geographic Allocation
(As of September 30, 2024)
|
Top 10 Holdings
| Name | Asset | Sector | Geographic | Percent |
| Apple Inc | US Equity | Technology | United States | 9.01% |
| Microsoft Corp | US Equity | Technology | United States | 8.45% |
| NVIDIA Corp | US Equity | Technology | United States | 8.35% |
| Alphabet Inc Cl A | US Equity | Technology | United States | 8.01% |
| Meta Platforms Inc Cl A | US Equity | Technology | United States | 6.07% |
| Roche Holding AG - Partcptn | International Equity | Healthcare | Other European | 4.95% |
| UnitedHealth Group Inc | US Equity | Healthcare | United States | 4.38% |
| Novartis AG Cl N | International Equity | Healthcare | Other European | 4.21% |
| Eli Lilly and Co | US Equity | Healthcare | United States | 3.60% |
| Thermo Fisher Scientific Inc | US Equity | Healthcare | United States | 3.58% |
Performance Data
(As of September 30, 2024)
|
|
Return (%)
|
Annualized Return (%)
|
|
Return
|
1
Mth
|
3
Mth
|
6
Mth
|
YTD
|
1
Yr
|
3
Yr
|
5
Yr
|
10
Yr
|
|
Fund
|
0.55
|
2.43
|
12.53
|
24.89
|
35.90
|
7.42
|
17.20
|
17.88
|
|
Benchmark
|
2.54
|
5.44
|
9.22
|
20.44
|
31.13
|
10.10
|
12.49
|
11.51
|
|
Quartile Ranking
|
4
|
4
|
1
|
1
|
1
|
3
|
1
|
1
|
|
Calendar Return (%)
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
2016
|
2015
|
2014
|
|
Fund
|
30.30
|
-20.76
|
3.04
|
47.89
|
35.10
|
7.19
|
31.68
|
-3.46
|
30.40
|
18.40
|
|
Benchmark
|
19.37
|
-12.64
|
17.62
|
13.15
|
21.41
|
-1.79
|
16.29
|
5.18
|
16.88
|
13.97
|
|
Quartile Ranking
|
1
|
4
|
4
|
1
|
1
|
1
|
1
|
4
|
1
|
1
|